You are here

Clinical Trials: Heart Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, December 3, 2018 - 12:00
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Recruiting
Posted: Tuesday, November 20, 2018 - 12:00
Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Device: VB-C01
Sponsors:   Viscofan;   Ministerio de Ciencia e Innovación, Spain
Recruiting
Posted: Thursday, October 4, 2018 - 12:00
Condition:   Cardiomyopathy, Familial
Interventions:   Other: Electrocardiogram;   Other: physical examination;   Other: echocardiography;   Biological: blood test
Sponsor:   University Hospital, Montpellier
Recruiting
Posted: Thursday, June 28, 2018 - 12:00
Condition:   Dilated Cardiomyopathy
Intervention:   Biological: Bone marrow derived mononuclear cells and G-CSF
Sponsor:   Barts & The London NHS Trust
Not yet recruiting
Posted: Tuesday, May 15, 2018 - 12:00
Condition:   HLHS
Intervention:   Biological: Longeveron Mesenchymal Stem Cells
Sponsor:   Longeveron LLC
Recruiting
Posted: Thursday, March 22, 2018 - 12:00
Condition:   Cardiac AL Amyloidosis
Interventions:   Drug: Doxycycline;   Drug: Standard of care therapy
Sponsor:   IRCCS Policlinico S. Matteo
Not yet recruiting
Posted: Monday, March 12, 2018 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, March 7, 2018 - 12:00
Conditions:   Refractory Angina;   Chronic Myocardial Ischemia
Interventions:   Device: CardiAMP Cell Therapy System;   Other: Sham Treatment
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Tuesday, February 13, 2018 - 12:00
Conditions:   Hypoplastic Left Heart Syndrome;   Heart Defects, Congenital;   Pediatric Disorder
Intervention:   Biological: Autologous Human Placental Cord Blood Mononuclear Cells
Sponsor:   Murdoch Childrens Research Institute
Not yet recruiting
Posted: Thursday, February 1, 2018 - 12:00
Condition:   Heart Failure
Interventions:   Drug: CardioCell;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Not yet recruiting

Pages